Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Panbela Therapeutics Announced Abstract For SBP-101 Accepted For Poster Presentation At American Association For Cancer Research

Author: Benzinga Newsdesk | January 30, 2024 09:18am

Poster Presentation

Title: Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models
Session Category: Experimental and Molecular Therapeutics

Session Title: Novel Antitumor Agents 6

Session Date and Time: Wednesday, April 10, 9:00-12:30

Abstract #: 7154
Additional meeting information can be found on the AACR website: https://www.aacr.org/meeting/aacr-annual-meeting-2024/abstracts/
The abstract and poster will also be available on the Company's website at https://panbela.com/events-presentations/ once the information has been released by AACR.

Posted In: PBLA